LiquidSMARTS℠

As Global Practice General Manager, I lead a consulting and training practice area, and head the Sales-as-a-Service team. I co-manage the Executive In Residence practice with my partners.
As founder, I am responsible for overall firm top-line revenue generation, talent acquisition, strategic partner development, and general services administration.

We help the world’s leading healthcare organizations achieve:
- 50% faster deal progression
- 40% YOY increase in pipeline size
- 25% more upselling opportunities
- 20% increase in closing rates
- 15% increase in depth of clinical discussions
- 10% reduction in time to first meaningful customer engagement

Founder & CEO

Health Innovation Capital

General Partner in Fund 1 and Venture Partner for Digital Health and Healthcare Services portfolio development

Venture Partner, Digital Health & Technology Enabled Services

syd™

Develop and deploy a sustainable go-to-market to scale at 3 digit growth rates. Recruit and support market-developing pilots with the Fortune 500, and strategic alliances. Support the product team in customer engagement, and develop academic and industry thought leadership opportunities.

Global Chief Revenue Officer

SimulConsult, INC.

CRO in Residence

EtherMed AI

Commercial Operations Head - in Residence

Vastmindz

Generate Sales, partnerships and operational support and consultation.

Commercialization Head in Residence

Total Innovation Group, Inc. (TIGI)

Senior Partner, Global Healthcare Practice Principal

TIGI is a commercial operations consulting and training firm serving private sector clients in the health care, defense, information technology, and services industries.

Partner, Global Healthcare Practice Principal

GFW Limited

Consultancy with clients develop and accelerate selling capital equipment, as well as consumables and durable medical equipment into hospitals and health systems. These projects leveraged expertise and direct experience in Radiology, GI, Surgery, Anesthesia, Respiratory Therapy, Clinical Laboratory, Molecular Diagnostics.

Principal

Roche Diagnostics

Manage Sales Territory Development for Molecular Diagnostics Product Portfolio in CA, NV, and UT.

Sr. Molecular Accounts Manager

Manage Sales Territory for IVD Product Portfolio in CA and HI

Sr. Account Manager

Advantage Medical

Manage and develop independent medical supply and capital distribution business.

Independent Contractor

We're all afraid of something. The good news: Fear doesn't have to hold you back in healthcare sales. 

In fact, it can do just the opposite. You can turn fear into fuel that drives you to unprecedented success.

With $4B+ in market cap unlocked for my clients, 50,000+ healthcare sales professionals trained, and 31 million lives improved by better healthcare, I've discovered what others miss: healthcare sales requires a fundamentally different approach. 

While others chase quick fixes and generic sales tactics, I help leaders align with natural patterns in human behavior, market dynamics, and organizational systems to achieve extraordinary results. Utilizing our Pain-Dominant logic, we help align sales and marketing actions to focus on key outcomes.

I've been a field sales rep in healthcare. I've managed my father's ophthalmology practice during his battle with ALS. I've been a trusted advisor in healthcare for two decades. Here's what this experience has taught me: 

Winning in healthcare sales requires more than just the right tools — it demands a deep understanding of human nature, the courage to transform fear into fuel, and total commitment to the outcomes that you, your clients, and their patients deserve.

This isn't theory. It's battle-tested wisdom supported by evidence from:
• 20+ years developing healthcare sales leaders as a 3rd party
• Hands-on healthcare management experience
• My PhD in management and MBA in marketing
• 100+ coaching clients promoted to executive roles in the last 5 years
• A lifetime in sales (starting at age 11) to relate to your situation

Today, I help healthcare sales leaders across the globe develop their distinctive edge by teaching them to:
• Recognize natural patterns in complex healthcare systems
• Transform fear into a strategic advantage
• Achieve sustainable results where others see only obstacles

Ready to turn your fear into fuel for success? Let's connect. Whether you're looking to scale your team's performance, transition to healthcare sales, or unlock your next level of leadership, I'm here to help.

📩 DM me here on LinkedIn
🌐 Visit www.liquidsmarts.com

Gunter Wessels, PhD, MBA

Illumina

Working to help the healthcare ecosystem integrate genomics and other data into equitable care and whole person health. Connecting Healthtech and payers.  Fighting the good fight.

Lead, Market Access - Health Systems

Independent

Precision Medicine Advisor and Principal Consultant

CommonSpirit Health

The Precision Medicine Alliance is a partnership between Dignity Health and Catholic Health Initiatives, two of the nation's largest health systems - now merged as CommonSpirit Health. The Alliance represents the largest community-based precision-medicine program in the nation, offering patients faster and more accurate genomic diagnostic and treatment protocols. The Precision Medicine Alliance platform will ultimately be available at more than 150 hospitals and care centers across the U.S., serving a potential patient population of approximately 12 million patients annually.

Lead - Precision Medicine

Catholic Health Initiatives

Co-leading a new nationally-partnered initiative to facilitate and expand access to advances in genomic and other advanced diagnostic technologies in the communities we serve.  Initial focus in is oncology.

Administrative Vice President, Precision Medicine

Working within the Catholic Health Initiatives (CHI) Institute for Research and Innovation (CIRI) to promote and progress key initiatives across the 3 CIRI business units: Center for Translational Research, Center for Clinical Research, and Center for Healthcare Innovation. www.chiresearch.org

Director, Business Development and Market Relations, CIRI

Actinium Pharmaceuticals, Inc.

Managed platform applications of radioimmunotherapy, strategic collaborations, licensing, and pre-clinical therapeutic development program management.  Currently consulting for Actinium (1/2006- now) regarding strategy/ preclinical applications and program management.  API is the leader in the research, development and commercialization of the alpha emitting isotopes bismuth 213 (Bi-213) and actinium 225 (Ac-225) for fighting cancer and other cellular diseases. The Company currently has two clinical trials underway and a number of preclinical initiatives. 
By utilizing the proven targeting capabilities of monoclonal antibodies (mAbs), API is able to deliver its proprietary isotopes directly to tumor cells. This targeted therapy delivers a powerful focused energy to the selected cell, disrupting its internal machinery and thereby eliminating it from the patient’s body while sparing nearby healthy cells.

Consulting Advisor; former Manager of Research and Development

Complete Genomics Inc.

Part of a cross-functional Market Development Team working with key stakeholders to deliver genomic information into healthcare.

Clinical Market Director

Lead business alliances in Personalized Medicine, molecular diagnostics, and biomarker research and development. Manage partnered diagnostic/ product development and CLIA MDx services portfolio.  Responsible for industry relations and strategic marketing for the Center's clinical trial services, biomarker assay development, and biorepository/ sample procurement businesses.  As an entity of Catholic Health Initiatives (CHI), a 73 hospital health care provider, I work to leverage the strengths of CHI to the CTR's mission of improving healthcare through innovations in diagnostics, prognostics, and companion therapeutic tests.

About the CTR:
CHI’s Center for Translational Research is an emerging participant and partner in the realization of personalized medicine and the utilization of biomarkers in the discovery, development, and commercialization of novel diagnostics and therapeutic companion assays.  The CTR, based on the campus of St. Joseph Medical Center, Towson, MD., is a venture of Catholic Health Initiatives (2009 revenue of $8.6B; 6th largest Healthcare provider in the US)) who provides world class healthcare through its 72 hospitals in 18 states.  The CTR’s CLIA laboratory provides tests for genomic markers that guide patient treatment, and will expand testing offerings as the personalized medicine market expands. The CTR will leverage its CLIA testing, specimen procurement, biorepository, and custom development capabilities enabeling new and better treatment options for patients.  The CTR will also act as an innovation catalyst for the CHI system focusing on personalized medicine in the healthcare setting.

Director, Business Development and Marketing; Center for Translational Research

Strategic Diagnostics

Lead the strategic and tactical marketing activities for the immunoassay and custom antibody development/production services to the diagnostic, pharmaceutical and academic markets. 
SDIX offers a full suite of integrated immuno-solution capabilities including assay design, development and production. In life science markets, SDIX capabilities are being used to help discover the mechanisms of disease, facilitate the development of new drugs, and provide mechanisms for rapid diagnosis.
Recent Information:
www.sdix.com/pdf/Final%20Usher%20Release%20061908.pdf

www.genengnews.com/articles/chitem.aspx?aid=2428&amp;pn=6

www.genomeweb.com/proteomics/nci-awards-strategic-diagnostics-first-round-funding-develop-antibodies

Sr. Director, Market Development

TMS BioScience Labs

TMS BioScience specializes in therapeutic drug monitoring of immunosuppressant drug levels in organ transplant patients. Pleasant Hooper,M.D. is a leading scientist in the application of tandem mass spectrometry (MS/MS) for biochemical genetic screening of newborns. His knowledge and experience with MS/MS applications led Dr. Hooper to develop a novel & vastly improved method of performing analysis of immunosuppressant drug levels (patent pending). In addition, he developed a proprietary sampling process, HomeTrak™ (pat. pending),that is of great benefit to both the patient and the clinician . TMS Bioscience lab is utilizing these improved technologies to provide the most accurate analysis of a patient’s immunosuppressant drug levels and to improve patient compliance.  The staff of TMS Bioscience is committed to serving the transplant community – both patients and physicians.

Advisory Board Member

GenVis Labs/ Bovigen (Purchased by Pfizer 2008)

Lead the start up and growth of a venture-backed biomedical and agricultural molecular diagnostics company that was acquired by Pfizer in 2007. Conducted all business development and marketing activities for the molecular diagnostic contract genetic analysis portfolio of the company.  Pursued and executed institutional and commercial collaborative ventures for novel biomarker discovery in oncogene variants and inherited genetic metabolic disorders.   Performed competitive analysis and technology surveys within the molecular diagnostic markets. Assessed commercial opportunities for integrating next generation sequencing, expression analysis, methylation, and SNP analysis technologies into GenVis’ portfolio.

VP, Scientific Operations

Pan-sector leader with broad experience in the development and commercialization of healthcare, genomic and proteomic diagnostic, research, and drug development services and products.  Skilled alliance builder with a history of growing healthcare and life sciences businesses through fruitful relationships, market driven strategies and nimble corporate governance.  Able to integrate the technical, financial, market, payer, and regulatory facets of biomedical business into opportunities for growth.  

Specialties: Personalized and Precision Medicine, Molecular Diagnostics, In-Licensing,  alliances management, mAb therapeutics, biomedical and healthcare market analysis, strategic marketing

taplio

The Battle

Gunter Wessels, PhD, MBA

Damon Hostin

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?